ABSTRACT
PURPOSE: The presence of a contralateral patent processus vaginalis (CPPV) is a risk factor for a metachronous hernia and may alter the surgical approach in unilateral cryptorchidism. We prospectively investigated the prevalence of a CPPV and compared the results between ultrasound (US) and transinguinal laparoscopy (TIL). MATERIALS AND METHODS: We analyzed a single surgeon's experience with preoperative US, TIL, and inguinal orchiopexy. We included 74 patients with a palpable (or identified by US) cryptorchidism with patent processus vaginalis who underwent inguinal orchiopexy. We performed an inguinal exploration when we could identify an opened internal ring through TIL. RESULTS: The prevalence of a CPPV was 18.9%. There was no significant difference in the occurrence of a CPPV by laterality, age, gestational age, or location of testis. A CPPV was detected 10 patients by US and in 15 patients by TIL, but one of them was revealed to be a blind pouch. The sensitivity and the specificity of US were 71.4% and 100%, respectively. Four CPPV cases were undiagnosed by US; all had a narrow internal ring. The accuracy of US was dependent on the width of the CPPV and the morphology of the internal ring. CONCLUSIONS: It was considerable that about 20% of patients with unilateral cryptorchidism had a CPPV, a risk factor for metachronous hernia. The presence of a CPPV in unilateral cryptorchidism should be considered in clinical practice.
Subject(s)
Humans , Male , Cryptorchidism , Gestational Age , Hernia , Laparoscopy , Orchiopexy , Prevalence , Prospective Studies , Risk Factors , Sensitivity and Specificity , TestisABSTRACT
PURPOSE: Peroxiredoxins(PRDXs) are antioxidant enzymes that play an important role on cell differentiation, proliferation and apoptosis. In this study, we investigated if the expression levels of PRDX I were related to bladder cancer. MATERIALS AND METHODS: The mRNA level of PRDX I was examined via real time polymerase chain reaction(PCR) in 186 cancer specimens from patients with primary bladder cancer, 73 corresponding samples of normal looking bladder mucosae surrounding the cancer and 21 samples of normal bladder mucosae. We investigated the correlation between the expression levels of PRDX I and the clinico-pathological parameters of the 154 patients who could be followed up more than three years. RESULTS: The expression levels of PRDX I in bladder cancer(0.73pg/ml) were significantly higher that that in the normal bladder mucosae (0.04 pg/ml)(p<0.01) or that in the corresponding normal bladder mucosae surrounding the cancer(0.38pg/ml)(p<0.01). The expression level of PRDX I was not significantly enhanced in the non-recurred(0.87pg/ml) superficial bladder tumor patients compared with the recurred superficial bladder tumor patients(0.63pg/ml), but it was significantly enhanced in the non-progressed(0.82pg/ml) patients compared with the progressed (0.50pg/ml) patients(p<0.05 for each). CONCLUSIONS: An enhanced expression of PRDX I is strongly associated with the development of bladder cancer. Moreover, enhanced expressions of PRDX I are also positively associated with a low rate of progression of bladder cancer, and this might be useful as a marker for assessing progression in human bladder cancers.
Subject(s)
Humans , Apoptosis , Cell Differentiation , Mucous Membrane , Peroxiredoxins , RNA, Messenger , Urinary Bladder , Urinary Bladder NeoplasmsABSTRACT
Congenital agenesis of the seminal vesicle is commonly associated with mullerian duct cysts and frequently combined with anomalies of the vas deferens or urinary tract. We report a case of a 29 year-old man with congenital agenesis of the seminal vesicle without any associated anomaly of the urogenital organs. He had infertility for 2 years and two semen analyses revealed azoospermia. There was no abnormal finding in physical examination of the testis, epididymis, or vas deferens. However, we could not locate the seminal vesicles in a transrectal ultrasound and computed tomography. We referred him to an infertility clinic for assisted reproductive technology.
Subject(s)
Humans , Male , Azoospermia , Epididymis , Infertility , Physical Examination , Semen Analysis , Seminal Vesicles , Testis , Urinary Tract , Vas DeferensABSTRACT
Congenital agenesis of the seminal vesicle is commonly associated with mullerian duct cysts and frequently combined with anomalies of the vas deferens or urinary tract. We report a case of a 29 year-old man with congenital agenesis of the seminal vesicle without any associated anomaly of the urogenital organs. He had infertility for 2 years and two semen analyses revealed azoospermia. There was no abnormal finding in physical examination of the testis, epididymis, or vas deferens. However, we could not locate the seminal vesicles in a transrectal ultrasound and computed tomography. We referred him to an infertility clinic for assisted reproductive technology.